Inhaled Glucocorticoid Use and the Risk of Osteoporosis in Asthmatic Patients

Background: Recently many studies have focused on the possible role of corticosteroids inhalation on osteoporosis in asthma patients. This study aimed to determine whether the indicatives of bone formation or resorption are different between asthma patients with healthy subjects. Materials and Metho...

Full description

Bibliographic Details
Main Authors: Mojtaba Eizadi, Mohammad Taghi Goodarzi
Format: Article
Language:English
Published: Mazandaran University of Medical Sciences and Health Services 2017-11-01
Series:Research in Molecular Medicine
Subjects:
Online Access:http://rmm.mazums.ac.ir/browse.php?a_code=A-10-927-1&slc_lang=en&sid=1
_version_ 1818242285087752192
author Mojtaba Eizadi
Mohammad Taghi Goodarzi
author_facet Mojtaba Eizadi
Mohammad Taghi Goodarzi
author_sort Mojtaba Eizadi
collection DOAJ
description Background: Recently many studies have focused on the possible role of corticosteroids inhalation on osteoporosis in asthma patients. This study aimed to determine whether the indicatives of bone formation or resorption are different between asthma patients with healthy subjects. Materials and Methods: To achieve this outcome, twenty one middle-aged asthma patients treated with inhaled corticosteroid and the same number healthy individuals matched for age (38 ± 6.5 years of old) participated in this study by accessible sampling. All subjects were non-trained and no smoker. Serum osteocalcin (OC), alkaline phosphatase (ALP) and cross-linked telopeptides of type I collagen (CTX) were measured to assess and compare bone formation and resorption between 2 groups. An Independent sample T-test was used to compare all variables between asthma and healthy subjects. Results: Significant differences were not observed in body weight and other anthropometrical markers between 2 groups (p > 0.05). Serum osteocalcin have shown a borderline significant lower in asthma patients than healthy subjects (p = 0.051). ALP was significantly lower in asthma patients than healthy subjects (p = 0.021). But serum CTX levels were higher in asthma patients than in healthy subjects (p=0.014). Conclusion: Based on these finding, it is appear that inhaled corticosteroid in asthma patients can be affect bone turnover in asthma patients, although more research is needed to further explore any potential link between corticosteroids and osteoporosis.  
first_indexed 2024-12-12T13:42:48Z
format Article
id doaj.art-c9803c12ecce43cd88ee442be6a3e144
institution Directory Open Access Journal
issn 2322-1348
2322-133X
language English
last_indexed 2024-12-12T13:42:48Z
publishDate 2017-11-01
publisher Mazandaran University of Medical Sciences and Health Services
record_format Article
series Research in Molecular Medicine
spelling doaj.art-c9803c12ecce43cd88ee442be6a3e1442022-12-22T00:22:46ZengMazandaran University of Medical Sciences and Health ServicesResearch in Molecular Medicine2322-13482322-133X2017-11-01544149Inhaled Glucocorticoid Use and the Risk of Osteoporosis in Asthmatic PatientsMojtaba Eizadi0Mohammad Taghi Goodarzi1 1. Department of Exercise Physiology, Saveh Branch, Islamic Azad University, Saveh, Iran. 2. Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan , Iran Background: Recently many studies have focused on the possible role of corticosteroids inhalation on osteoporosis in asthma patients. This study aimed to determine whether the indicatives of bone formation or resorption are different between asthma patients with healthy subjects. Materials and Methods: To achieve this outcome, twenty one middle-aged asthma patients treated with inhaled corticosteroid and the same number healthy individuals matched for age (38 ± 6.5 years of old) participated in this study by accessible sampling. All subjects were non-trained and no smoker. Serum osteocalcin (OC), alkaline phosphatase (ALP) and cross-linked telopeptides of type I collagen (CTX) were measured to assess and compare bone formation and resorption between 2 groups. An Independent sample T-test was used to compare all variables between asthma and healthy subjects. Results: Significant differences were not observed in body weight and other anthropometrical markers between 2 groups (p > 0.05). Serum osteocalcin have shown a borderline significant lower in asthma patients than healthy subjects (p = 0.051). ALP was significantly lower in asthma patients than healthy subjects (p = 0.021). But serum CTX levels were higher in asthma patients than in healthy subjects (p=0.014). Conclusion: Based on these finding, it is appear that inhaled corticosteroid in asthma patients can be affect bone turnover in asthma patients, although more research is needed to further explore any potential link between corticosteroids and osteoporosis.  http://rmm.mazums.ac.ir/browse.php?a_code=A-10-927-1&slc_lang=en&sid=1Asthma Bone turnover Osteocalcin Corticosteroid
spellingShingle Mojtaba Eizadi
Mohammad Taghi Goodarzi
Inhaled Glucocorticoid Use and the Risk of Osteoporosis in Asthmatic Patients
Research in Molecular Medicine
Asthma
Bone turnover
Osteocalcin
Corticosteroid
title Inhaled Glucocorticoid Use and the Risk of Osteoporosis in Asthmatic Patients
title_full Inhaled Glucocorticoid Use and the Risk of Osteoporosis in Asthmatic Patients
title_fullStr Inhaled Glucocorticoid Use and the Risk of Osteoporosis in Asthmatic Patients
title_full_unstemmed Inhaled Glucocorticoid Use and the Risk of Osteoporosis in Asthmatic Patients
title_short Inhaled Glucocorticoid Use and the Risk of Osteoporosis in Asthmatic Patients
title_sort inhaled glucocorticoid use and the risk of osteoporosis in asthmatic patients
topic Asthma
Bone turnover
Osteocalcin
Corticosteroid
url http://rmm.mazums.ac.ir/browse.php?a_code=A-10-927-1&slc_lang=en&sid=1
work_keys_str_mv AT mojtabaeizadi inhaledglucocorticoiduseandtheriskofosteoporosisinasthmaticpatients
AT mohammadtaghigoodarzi inhaledglucocorticoiduseandtheriskofosteoporosisinasthmaticpatients